Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-02-19
1994-03-22
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3702
Patent
active
052964663
ABSTRACT:
The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock.
REFERENCES:
patent: 4061736 (1977-12-01), Morris et al.
patent: 4584130 (1986-04-01), Bucci et al.
patent: 4598064 (1986-07-01), Walder
patent: 4751068 (1988-06-01), Bickar et al.
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5082642 (1992-01-01), Bickar et al.
Wang et al., Nitric oxide hemoglobin in mice and rats in endotoxic shock, Chemical Abstracts, vol. 115, No. 15, issued 1991, Oct. 14, p. 659m, col. 1, the abstract-No. 156 199a, Life Sci. 1991, 49(11), PL55-PL60.
Westenberger et al., Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome, Chemical Abstracts, vol. 114, No. 21, issued 1991, May 27, p. 597, col. 2-p. 598, col. 1, the abstract-No. 204 845m, Free Radical Res. Commun. 1990, 11(1-3), 167-178.
Wang et al., "Nitric Oxide Hemoglobin in Mice and Rats in Endotoxic Shock", Lifesciences, 49, p155-p160, 1991.
Westenberger et al., "Formation of Free Radicals and Nitric Oxide Derivative of Hemoglobin in Rats During Shock Syndrome", Free Radical Res. Commun., 11, 167-178, 1990.
Kosaka et al., "Detection of Nitric Oxide Production in Lipopoysaccharide-Treated Rats by ESR Using Carbon Monoxide Hemoglobin", Biochem. and Biophys. Res. Commun., 1119-1124, Apr. 30. 1992.
Stamler et al., "Biochemistry of Nitric Oxide and Its Redox-Activated Forms", Science, 258, 1898-1902, 1992.
Koshland, Jr., "Editorial-The Molecule of the Year", (Science, 258, 1861) 1992.
Culotta et al., "No News Is Good News", Science, 258, 1862-1865, 1992.
Bickar et al., "Carbon Monoxide-Driven Reduction of Ferric Heme and Heme Proteins," Journal of Biological Chemistry, 259(17): 10777-10783, 1984, published in USA.
Martin et al., "Selective Blockade of Endothelium-Dependent and Glyceryl Trinitrate-Induced Relaxation by Hemoglobin and by Methylene Blue in the Rabbit Aorta," The Journal of Pharmacology and Experimental Therapeutics, 232(3):708-716, 1985, published in USA.
Buga et al., "Endothelium-Derived Nitric Oxide Relaxes Nonvascular Smooth Muscle," European Journal of Pharmacology, 161:61-72, 1989, published in Europe.
Stuehr et al., "Activated Murine Macrophages Secrete a Metabolite of Arginine with the Bioactivity of Endothelium-Derived Relaxing Factor and the Chemical Reactivity of Nitric Oxide," J. Exp. Med., 169:1011-1020, 1989, published in USA.
Stuehr et al., "Synthesis of Nitrogen Oxides from L-Arginine by Macrophage Cytosol: Requirement for Inducible and Constitutive Components," Biochemical and Biophysical Research Communications, 161(2):420-426, 1989, published in USA.
Torti et al., "A Macrophage Factor Inhibits Adipocyte Gene Expression: An in Vitro Model of Cachexia," Science, 229:867-871, 1985, published in USA.
Palmer et al., "Vascular Endothelial Cells Synthesize Nitric Oxide from L-Arginine," Nature, 333:664-666, 1988, published in Europe.
Old, Lloyd J., "Tumor Necrosis Factor (TNF)," 230:630-632, 1985, published in USA.
Yoshida and Kasama, "Biotransformation of Nitric Oxide," Environmental Health Perspectives, 73:201-206, 1987, published in USA.
Schmidt et al., "Arginine is a Physiological Precursor of Endothelium-Derived Nitric Oxide," European Journal of Pharmacology, 154:213-216, 1988, published in Europe.
Reif and Simmons, "Nitric Oxide Mediates Iron Release from Ferritin," Archives of Biochemistry and Biophysics, 283(2):537-541, 1990, published in USA.
Kruszyna et al., "Nitrite Conversion to Nitric Oxide in Red Cells and Its Stabilization as a Nitrosylated Valency Hybrid of Hemoglobin," The Journal of Pharmacology and Experimental Therapeutics, 241(1):307-313, 1987, published in USA.
Kosaka et al., "The Interaction Between Nitrogen Oxides and Hemoglobin and Endothelium-Derived Relaxing Factor," Free Radical Biology and Medicine, 7:653-658, 1989, published in USA.
Chevion et al., "Iron-Nitrosyl Bond Configuration in Nitrosyl-Hemoproteins: A Comparative EPR Study of Hemoglobin A and Hemoglobin Kansas," Israel Journal of Chemistry, 15:311-317, 1976, published in Israel.
Collier and Vallance, "Second Messenger Role for NO Widens to Nervous and Immune Systems," Trends in Pharmacological Sciences Including Toxicological Sciences, Elseview Science Publishers, Ltd., front page and pp. 428-431, 1989, published in United Kingdom.
Ignarro et al., "Endothelium-Derived Relaxing Factor Produced and Released from Artery and Vein is Nitric Oxide," Proc. Natl. Acad. Sci. USA, 84:9265-9269, 1987, published in USA.
Murray et al., "Stabilization and Partial Characterization of Endothelium-Derived Relaxing Factor from Cultured Bovine Aortic Endothelial Cells," Biochemical and Biophysical Research Communications, 141(2):689-696, 1986, published in USA.
Marletta, Michael A., "Nitric Oxide: Biosynthesis and Biological Significance," name of publication unknown, Elseview Science Publishers, Ltd., pp. 448-493, 1989, published in United Kingdom.
Geokas et al., "Methemalbumin in the Diagnosis of Acute Hemorrhagic Pancreatitis," Annals of Internal Medicine, 81:483-486, 1974, published in USA.
Murray et al., "Measurement of Methaemalbumin in Plasma," J. Clin. Path., 26:446-447, 1973, published in Europe.
Muller-Eberhard and Morgan, "Porphyrin-Binding Proteins in Serum," Annals New York Academy of Sciences, 224:624-649, 1975, published in USA.
Baur, Ernst W., "The Evolution of Methaemalbumin," Comp. Biochem. Physiol., 30:657-664, 1969, published in Europe.
Chong et al., "Determination of Methaemalbumin in Plasma," J. Clinical Pathology, 20:211-212, 1967, published in Europe.
Marden et al., "Flash Photolysis of the Serum Albumin-Heme-CO Complex," Biochemistry, 28(10):4422-4426, 1989, published in USA.
Bonkovsky et al., "Intravenous Heme-Albumin in Acute Intermittent Prophyria: Evidence for Repletion of Depatic Hemoproteins and Regulatory Heme Pools," The American Journal of Gastroenterology, 86(8):1050-1056, 1991, published in USA.
Bone, Roger C., "The Pathogenesis of Sepsis," Ann. Int. Med. 115:457-469, 1991, published in USA.
Bone, Roger C., "A Critical Evaluation of New Agents for the Treatment of Sepsis," JAMA 266(12):1686-1691, 1991, published in USA.
Glauser, M. P., et al., "Septic Shock: Pathogenesis," The Lancet, 338:732-736, 1991, published in UK.
Johnston, J., "Molecular Science Sets Its Sights on Septic Shock," J. NIH Res. 3:61-65, 1991, Published in USA.
Moncada, S. and E. A. Higgs, "Endogenous Nitric Oxide: Physiology, Pathology, and Clinical Relevance," Eur. J. Clin. Invest. 21:361-374, 1991, published in Europe.
Moncada, S., et al., "The L-Arginine: Nitric Oxide Pathway," J. Cardiovascular Pharm. 7(Suppl. 3):S1-S9, 1991. Published in USA.
Moncada, S., et al., "Nitric Oxide: Physiology, Pathopysiology, and Pharmacology," Pharmacological Reviews 43(2):109-142. Published in USA. (1991).
Parratt, J. R., and J. C. Stoclet, "Possible Role of Nitric Oxide in Refractory Hypotension Associated with Sepsis and Endotoxaemia and with Multiple Organ Failure," Applied Cardiopulmonary Pathophysiology 4:143-149, 1991. Published in the Netherlands.
Snell, R. J., and J. E. Parrillo, "Cardiovascular Dysfunction in Septic Shock," Chest 99(4):1000-1009, 1991. Published in USA.
Wang, Q., et al., "Nitric Oxide Hemoglobin in Mice and Rats in Endotoxic Shock," Life Sciences 49:PL-55-60, 1991. Published in USA.
Kilbourn et al., "N.sup.G -Methyl-L-arginine Inhibits Tumor Necrosis Factor-Induced Hypotension: Implications for the Involvement of Nitric Oxide," Proc. Natl. Acad. Sci. USA, 87:3629-3632, 1990, published in U.S.A.
Palmer et al., "Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor," Nature, 327:524-526, 1987, published in England.
Moncada et al., "Generation of Prostacycline and Endothelium-Derived Relaxing Facto
Bonaventura Joseph
De Angelo Joseph
Kilbourn Robert G.
Board of Regents , The University of Texas System
Duke University
Koh Choon
Strohtech, Inc.
Wityshyn Michael G.
LandOfFree
Inhibition of nitric oxide-mediated hypotension and septic shock does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of nitric oxide-mediated hypotension and septic shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of nitric oxide-mediated hypotension and septic shock will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437150